SEC Form 4 · accession 0001225208-18-001054
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
Jan 16, 2018
Accepted (ET)
Jan 16, 2018 · 5:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 16, 2018 | M | 50,994 | $36.56 | A | 50,994 | D | |
| Common Stock | Jan 16, 2018 | S | 50,994 | $61.63 | D | 0 | D | |
| Common StockF3 | Jan 16, 2018 | S | 50,608 | $61.63 | D | 62,766 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $36.56 | Jan 16, 2018 | M | 50,994 | D | May 4, 2012 | May 3, 2021 | Common Stock | 50,994 | 200,000 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- F3Holdings include shares acquired in dividend reinvestment transactions.
- F4The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.
Remarks
poaschechter.txt